Startups

Senior/Principal Scientist, Translational Biomarkers

NewLimit · South San Francisco · On-site

← All jobs
About NewLimit

NewLimit is extending human healthspan by unlocking regenerative potential. Backed by Kleiner Perkins.

About the role

NewLimit is seeking a Senior/Principal Scientist with deep expertise in molecular biology and translational biomarker assay development. In this role, you will lead the discovery, development, and qualification of pharmacodynamic (PD) biomarker assays that characterize the biological activity of our mRNA-LNP medicines in preclinical and IND-enabling studies.

What they're looking for

  • PhD in molecular biology, biochemistry, cell biology, or a related field or equivalent industry experience (5+ years)
  • Strong working knowledge of bioanalytical method qualification/validation principles for PD biomarker measurements, including familiarity with ICH M10 guidelines and fit-for-purpose frameworks
  • History of delivering results for bioanalytical projects -- you've discovered a PD biomarker or built an assay and solved all the problems along the way
  • Experience with primary cell culture and tissue-derived sample workflows
More about this role

NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.

NewLimit is seeking a Senior/Principal Scientist with deep expertise in molecular biology and translational biomarker assay development. In this role, you will lead the discovery, development, and qualification of pharmacodynamic (PD) biomarker assays that characterize the biological activity of our mRNA-LNP medicines in preclinical and IND-enabling studies. You will serve as a technical leader within our bioanalytical function, shaping PD biomarker strategy from discovery through fit-for-purpose qualification to advance our therapeutic programs toward clinical milestones.

  • Discover pharmacodynamic biomarkers to support the clinical development of drugs across multiple programs
  • Own the design, development, and qualification of PD...

Read the full posting on NewLimit's site ↗

Single Cell Technology

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.